Scientists used CRISPR technology to disable the cholesterol gene in a groundbreaking study, though widespread availability remains years away.

After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was down 5.44% at $49.93. This move lagged the S&P 500's daily loss of 0.08%. On the other hand, the Dow registered a loss of 0.61%, and the ...

Key opportunities in Saudi Arabia's synthetic biology market include leveraging government investments and biotechnology advancements driven by Vision 2030. The focus is on reducing oil dependence by ...

Cathie Wood’s ARK Invest added to several beaten-down technology and biotech names while trimming positions elsewhere. The investment manager made a notable purchase in gene-editing company CRISPR ...

CRISPR/Cas-based biosensors offer an opportunity to quantify neuroinflammation in Parkinson’s disease, advancing diagnostics ...

Researchers have used mouse models to study how cocaine addiction alters the brain, illuminating why relapse is common as ...

Tropic will establish a mother plantation to support commercial deployment of bananas resistant to fusarium wilt (TR4) from 2027.

As climate pressure mounts, new platforms tackle delivery, regulation, trait stacking, and data bottlenecks limiting agricultural genome editing.

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

CNN will debut a new original series, Wants To Live Forever, at 9 p.m. ET/PT on April 11. The six-episode series follows ...